SALT LAKE CITY, Sept. 28, 2022 /PRNewswire/ — Xenocor, a Utah-based medical device company, today announced that the FDA cleared the enhanced version of their Saberscope, the world’s first true HD, fog free, articulating, single-use laparoscope. The Saberscope is designed to improve patient safety and costs and reduce hassles such as fog, smoke and steam, workflow complexity and waste.
“The addition of the auto-focus capability will truly enhance the likelihood of swift adoption in the surgical marketplace. This would especially be true in procedures & specialties that target multiple quadrants of the abdomen due to requirements for refocusing of the image,” said Jarrod Kaufman, a General Surgeon from Brick, New Jersey.
Prior to the Saberscope, all laparoscopic procedures required cumbersome, expensive equipment that introduces unnecessary patient risk, hassles, cost, workflow complexity and waste. The burden on hospitals to clean scopes between uses presents enormous workflow complexity, as well as patient risk. Additionally, the towers represent a massive capital expense and a number of hidden costs, such as frequent and costly scope replacements.